Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TUSC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
OPTC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
FEZ1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927950 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ASMT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Homologene neighbors
LOC101929694 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANXA13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MUC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RASGRP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101929284 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLHDC7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NLRP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on